Pascal H. G. Duijf

6.2k total citations · 1 hit paper
82 papers, 4.0k citations indexed

About

Pascal H. G. Duijf is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pascal H. G. Duijf has authored 82 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 40 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Pascal H. G. Duijf's work include Cancer-related Molecular Pathways (21 papers), MicroRNA in disease regulation (17 papers) and DNA Repair Mechanisms (14 papers). Pascal H. G. Duijf is often cited by papers focused on Cancer-related Molecular Pathways (21 papers), MicroRNA in disease regulation (17 papers) and DNA Repair Mechanisms (14 papers). Pascal H. G. Duijf collaborates with scholars based in Australia, Iran and United States. Pascal H. G. Duijf's co-authors include Behzad Baradaran, Robert Benezra, Behzad Mansoori, Ali Mohammadi, Hans van Bokhoven, Kum Kum Khanna, Mahyar Aghapour, Morten F. Gjerstorff, Eloïse Dray and Annie Yang and has published in prestigious journals such as Cell, Nucleic Acids Research and Nature Communications.

In The Last Decade

Pascal H. G. Duijf

82 papers receiving 3.9k citations

Hit Papers

Heterozygous Germline Mutations in the p53 Homolog p63 Ar... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers

Pascal H. G. Duijf
Susan B. Olson United States
Wendy C. Weinberg United States
Lyn M. Duncan United States
Ilaria Malanchi United Kingdom
Dmitri Wiederschain United States
Kathy Q. Cai United States
Monica Venere United States
Michael T. Barrett United States
Susan B. Olson United States
Pascal H. G. Duijf
Citations per year, relative to Pascal H. G. Duijf Pascal H. G. Duijf (= 1×) peers Susan B. Olson

Countries citing papers authored by Pascal H. G. Duijf

Since Specialization
Citations

This map shows the geographic impact of Pascal H. G. Duijf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal H. G. Duijf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal H. G. Duijf more than expected).

Fields of papers citing papers by Pascal H. G. Duijf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal H. G. Duijf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal H. G. Duijf. The network helps show where Pascal H. G. Duijf may publish in the future.

Co-authorship network of co-authors of Pascal H. G. Duijf

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal H. G. Duijf. A scholar is included among the top collaborators of Pascal H. G. Duijf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal H. G. Duijf. Pascal H. G. Duijf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perera, Ganganath S., Xiaomin Huang, Paul Leo, et al.. (2025). Rapid and selective detection of TP53 mutations in cancer using a novel conductometric biosensor. Biosensors and Bioelectronics. 276. 117252–117252. 1 indexed citations
2.
Beecher, Kate, Malcolm Lim, Andrew W. Stacey, et al.. (2024). B7-H3 Expression in Breast Cancer and Brain Metastasis. International Journal of Molecular Sciences. 25(7). 3976–3976. 9 indexed citations
3.
Bhatia, Sugandha, Kum Kum Khanna, & Pascal H. G. Duijf. (2024). Targeting chromosomal instability and aneuploidy in cancer. Trends in Pharmacological Sciences. 45(3). 210–224. 11 indexed citations
4.
Rostamzadeh, Davoud, et al.. (2023). MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2. Clinical Breast Cancer. 23(7). e480–e490.e3. 3 indexed citations
5.
Paquet, Nicolas, Yan Coulombe, Justin Leung, et al.. (2023). The protein phosphatase EYA4 promotes homologous recombination (HR) through dephosphorylation of tyrosine 315 on RAD51. Nucleic Acids Research. 52(3). 1173–1187. 4 indexed citations
6.
Wiegmans, Adrian P., Pascal H. G. Duijf, Mark N. Adams, et al.. (2021). Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer. NAR Cancer. 3(2). zcab022–zcab022. 8 indexed citations
7.
Mansoori, Behzad, Nicola Silvestris, Ali Mohammadi, et al.. (2021). miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis. Genes. 12(2). 267–267. 37 indexed citations
8.
Srihari, Sriganesh, et al.. (2021). Targeting BRF2 in Cancer Using Repurposed Drugs. Cancers. 13(15). 3778–3778. 12 indexed citations
10.
Suraweera, Amila, Mark N. Adams, Pascal H. G. Duijf, et al.. (2021). Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer. British Journal of Cancer. 124(9). 1612–1612. 16 indexed citations
11.
12.
Mohammadi, Ali, Pascal H. G. Duijf, Behzad Baradaran, et al.. (2020). The role of miR‐34 in cancer drug resistance. Journal of Cellular Physiology. 235(10). 6424–6440. 30 indexed citations
13.
Mohammadi, Ali, Behzad Mansoori, Pascal H. G. Duijf, et al.. (2020). Restoration of miR‐330 expression suppresses lung cancer cell viability, proliferation, and migration. Journal of Cellular Physiology. 236(1). 273–283. 18 indexed citations
14.
Suraweera, Amila, Mark N. Adams, Pascal H. G. Duijf, et al.. (2020). Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer. British Journal of Cancer. 123(4). 591–603. 16 indexed citations
15.
Mansoori, Behzad, Ali Mohammadi, Morten F. Gjerstorff, et al.. (2019). miR‐142‐3p is a tumor suppressor that inhibits estrogen receptor expression in ER‐positive breast cancer. Journal of Cellular Physiology. 234(9). 16043–16053. 42 indexed citations
16.
Mansoori, Behzad, Ali Mohammadi, Zahra Asadzadeh, et al.. (2019). HMGA2 and Bach‐1 cooperate to promote breast cancer cell malignancy. Journal of Cellular Physiology. 234(10). 17714–17726. 37 indexed citations
17.
Vahidian, Fatemeh, Pascal H. G. Duijf, Elham Safarzadeh, et al.. (2019). Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?. Immunology Letters. 208. 19–29. 60 indexed citations
18.
Asadzadeh, Zahra, Behzad Mansoori, Ali Mohammadi, et al.. (2018). microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities. Journal of Cellular Physiology. 234(7). 10002–10017. 81 indexed citations
19.
Mansoori, Behzad, Ali Mohammadi, Mehri Ghasabi, et al.. (2018). miR‐142‐3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach‐1 expression. Journal of Cellular Physiology. 234(6). 9816–9825. 97 indexed citations
20.
Bongers, Ernie M.H.F., Pascal H. G. Duijf, Sylvia E. C. van Beersum, et al.. (2004). Mutations in the Human TBX4 Gene Cause Small Patella Syndrome. The American Journal of Human Genetics. 74(6). 1239–1248. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026